S&P 500   3,304.27 (-1.57%)
DOW   27,606.39 (-1.06%)
QQQ   264.80 (-2.04%)
AAPL   106.92 (-3.10%)
MSFT   197.87 (-2.48%)
FB   251.83 (-1.17%)
GOOGL   1,441.62 (-3.05%)
AMZN   2,930.29 (-2.61%)
NVDA   483.68 (-2.98%)
TSLA   436.51 (+3.09%)
BABA   271.28 (-1.61%)
CGC   16.36 (-0.24%)
GE   6.94 (-1.56%)
MU   50.34 (-1.26%)
AMD   74.37 (-2.85%)
T   29.03 (-0.14%)
F   7.28 (+0.00%)
ACB   6.50 (-5.66%)
GILD   64.30 (-1.14%)
NFLX   462.34 (-1.67%)
DIS   129.16 (-0.81%)
BAC   25.43 (+0.32%)
BA   163.67 (-2.30%)
S&P 500   3,304.27 (-1.57%)
DOW   27,606.39 (-1.06%)
QQQ   264.80 (-2.04%)
AAPL   106.92 (-3.10%)
MSFT   197.87 (-2.48%)
FB   251.83 (-1.17%)
GOOGL   1,441.62 (-3.05%)
AMZN   2,930.29 (-2.61%)
NVDA   483.68 (-2.98%)
TSLA   436.51 (+3.09%)
BABA   271.28 (-1.61%)
CGC   16.36 (-0.24%)
GE   6.94 (-1.56%)
MU   50.34 (-1.26%)
AMD   74.37 (-2.85%)
T   29.03 (-0.14%)
F   7.28 (+0.00%)
ACB   6.50 (-5.66%)
GILD   64.30 (-1.14%)
NFLX   462.34 (-1.67%)
DIS   129.16 (-0.81%)
BAC   25.43 (+0.32%)
BA   163.67 (-2.30%)
S&P 500   3,304.27 (-1.57%)
DOW   27,606.39 (-1.06%)
QQQ   264.80 (-2.04%)
AAPL   106.92 (-3.10%)
MSFT   197.87 (-2.48%)
FB   251.83 (-1.17%)
GOOGL   1,441.62 (-3.05%)
AMZN   2,930.29 (-2.61%)
NVDA   483.68 (-2.98%)
TSLA   436.51 (+3.09%)
BABA   271.28 (-1.61%)
CGC   16.36 (-0.24%)
GE   6.94 (-1.56%)
MU   50.34 (-1.26%)
AMD   74.37 (-2.85%)
T   29.03 (-0.14%)
F   7.28 (+0.00%)
ACB   6.50 (-5.66%)
GILD   64.30 (-1.14%)
NFLX   462.34 (-1.67%)
DIS   129.16 (-0.81%)
BAC   25.43 (+0.32%)
BA   163.67 (-2.30%)
S&P 500   3,304.27 (-1.57%)
DOW   27,606.39 (-1.06%)
QQQ   264.80 (-2.04%)
AAPL   106.92 (-3.10%)
MSFT   197.87 (-2.48%)
FB   251.83 (-1.17%)
GOOGL   1,441.62 (-3.05%)
AMZN   2,930.29 (-2.61%)
NVDA   483.68 (-2.98%)
TSLA   436.51 (+3.09%)
BABA   271.28 (-1.61%)
CGC   16.36 (-0.24%)
GE   6.94 (-1.56%)
MU   50.34 (-1.26%)
AMD   74.37 (-2.85%)
T   29.03 (-0.14%)
F   7.28 (+0.00%)
ACB   6.50 (-5.66%)
GILD   64.30 (-1.14%)
NFLX   462.34 (-1.67%)
DIS   129.16 (-0.81%)
BAC   25.43 (+0.32%)
BA   163.67 (-2.30%)
Log in
NYSE:BSX

Boston Scientific Stock Forecast, Price & News

$38.75
-0.92 (-2.32 %)
(As of 09/18/2020 01:21 PM ET)
Add
Compare
Today's Range
$38.75
Now: $38.75▼
$39.97
50-Day Range
$37.15
MA: $39.80▼
$42.23
52-Week Range
$24.10
Now: $38.75▼
$46.62
Volume271,161 shs
Average Volume10.34 million shs
Market Capitalization$55.44 billion
P/E Ratio13.74
Dividend YieldN/A
Beta0.95
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; percutaneous coronary interventions products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as various peripheral vessels; and structural heart therapies. Further, it provides stents, balloon catheters, wires, atherectomy systems to treat arterial diseases; thrombectomy and acoustic pulse thrombolysis systems, wires, and stents to treat venous diseases; and peripheral embolization devices, radioactive microspheres, ablation systems, and micro and drainage catheters to treat cancer. The company was founded in 1979 and is headquartered in Marlborough, Massachusetts.
Read More
Boston Scientific logo

Beat the Market (BTM) Rank™

Analyst Opinion: 3.5Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 3.1 5 -4 -3 -2 -1 -

Overall Beat the Market Rank™

2.07 out of 5 stars


Industry, Sector and Symbol

Stock Exchange NYSE
Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
SectorMedical
Current SymbolNYSE:BSX
Previous Symbol
CUSIP10113710
CIK885725
Webwww.bostonscientific.com
Phone508-683-4000

Debt

Debt-to-Equity Ratio0.59
Current Ratio1.87
Quick Ratio1.38

Price-To-Earnings

Trailing P/E Ratio13.74
Forward P/E Ratio39.95
P/E Growth4.26

Sales & Book Value

Annual Sales$10.74 billion
Price / Sales5.16
Cash Flow$2.26 per share
Price / Cash Flow17.11
Book Value$9.96 per share
Price / Book3.89

Profitability

EPS (Most Recent Fiscal Year)$1.58
Net Income$4.70 billion
Net Margins39.18%
Return on Equity12.86%
Return on Assets5.76%

Miscellaneous

Employees36,000
Outstanding Shares1,430,675,000
Market Cap$55.44 billion
Next Earnings Date10/28/2020 (Estimated)
OptionableOptionable
$38.75
-0.92 (-2.32 %)
(As of 09/18/2020 01:21 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive BSX News and Ratings via Email

Sign-up to receive the latest news and ratings for BSX and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Boston Scientific (NYSE:BSX) Frequently Asked Questions

How has Boston Scientific's stock been impacted by COVID-19?

Boston Scientific's stock was trading at $33.86 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, BSX shares have increased by 16.6% and is now trading at $39.49.
View which stocks have been most impacted by COVID-19.

Do Wall Street analysts recommend investors buy shares of Boston Scientific?

25 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Boston Scientific in the last year. There are currently 3 hold ratings, 19 buy ratings and 3 strong buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Boston Scientific.

When is Boston Scientific's next earnings date?

Boston Scientific is scheduled to release its next quarterly earnings announcement on Wednesday, October 28th 2020.
View our earnings forecast for Boston Scientific.

How were Boston Scientific's earnings last quarter?

Boston Scientific Co. (NYSE:BSX) issued its quarterly earnings data on Wednesday, July, 29th. The medical equipment provider reported $0.08 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of ($0.04) by $0.12. The medical equipment provider earned $2 billion during the quarter, compared to analysts' expectations of $1.68 billion. Boston Scientific had a net margin of 39.18% and a return on equity of 12.86%. Boston Scientific's revenue for the quarter was down 23.9% on a year-over-year basis. During the same period last year, the business earned $0.39 EPS.
View Boston Scientific's earnings history.

What price target have analysts set for BSX?

25 brokers have issued twelve-month target prices for Boston Scientific's shares. Their forecasts range from $25.00 to $58.00. On average, they expect Boston Scientific's share price to reach $45.00 in the next twelve months. This suggests a possible upside of 14.0% from the stock's current price.
View analysts' price targets for Boston Scientific.

Who are some of Boston Scientific's key competitors?

Some companies that are related to Boston Scientific include Abbott Laboratories (ABT), Medtronic (MDT), Intuitive Surgical (ISRG), Stryker (SYK), Becton Dickinson and (BDX), Edwards Lifesciences (EW), Baxter International (BAX), DexCom (DXCM), IDEXX Laboratories (IDXX), ResMed (RMD), Hologic (HOLX), Teleflex (TFX), Varian Medical Systems (VAR), Insulet (PODD) and Steris (STE).
View all competitors.

What other stocks do shareholders of Boston Scientific own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Boston Scientific investors own include NVIDIA (NVDA), Alibaba Group (BABA), Intel (INTC), Bank of America (BAC), CVS Health (CVS), Walt Disney (DIS), AT&T (T), Visa (V), Advanced Micro Devices (AMD) and salesforce.com (CRM).

Who are Boston Scientific's key executives?

Boston Scientific's management team includes the following people:
  • Mr. Michael F. Mahoney, Chairman, Pres & CEO (Age 55, Pay $3.57M)
  • Mr. Daniel J. Brennan, Exec. VP & CFO (Age 54, Pay $1.28M)
  • Mr. Edward F. Mackey, Exec. VP of Operations (Age 57, Pay $1.13M)
  • Mr. Joseph M. Fitzgerald, Exec. VP & Pres of Rhythm Management (Age 56, Pay $1.24M)
  • Mr. Kevin J. Ballinger, Exec. VP & Pres of Interventional Cardiology (Age 47, Pay $1.07M)

What is Boston Scientific's stock symbol?

Boston Scientific trades on the New York Stock Exchange (NYSE) under the ticker symbol "BSX."

Who are Boston Scientific's major shareholders?

Boston Scientific's stock is owned by a number of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (7.91%), Viking Global Investors LP (1.32%), Newport Trust Co (0.63%), Charles Schwab Investment Management Inc. (0.44%), Swiss National Bank (0.41%) and Sumitomo Mitsui Trust Holdings Inc. (0.40%). Company insiders that own Boston Scientific stock include Arthur C Butcher, Daniel J Brennan, David A Pierce, Desiree Ralls-Morrison, Edward F Mackey, Eric Francis Yves Thepaut, Halliday Hamish, Jeffrey B Mirviss, Jodi Euerle Eddy, John Bradley Sorenson, Joseph Michael Fitzgerald, Kevin J Ballinger, Maulik Nanavaty, Michael F Mahoney, Wendy Carruthers, Williamson Scott, Xin Warren Wang and Yoshiaki Fujimori.
View institutional ownership trends for Boston Scientific.

Which major investors are selling Boston Scientific stock?

BSX stock was sold by a variety of institutional investors in the last quarter, including Viking Global Investors LP, Senator Investment Group LP, Toronto Dominion Bank, Sumitomo Mitsui Trust Holdings Inc., Strs Ohio, Atalanta Sosnoff Capital LLC, Diamond Hill Capital Management Inc., and California Public Employees Retirement System. Company insiders that have sold Boston Scientific company stock in the last year include Arthur C Butcher, Daniel J Brennan, David A Pierce, Desiree Ralls-Morrison, Eric Francis Yves Thepaut, Jeffrey B Mirviss, John Bradley Sorenson, Joseph Michael Fitzgerald, Maulik Nanavaty, and Wendy Carruthers.
View insider buying and selling activity for Boston Scientific.

Which major investors are buying Boston Scientific stock?

BSX stock was purchased by a variety of institutional investors in the last quarter, including Winslow Capital Management LLC, Vanguard Group Inc., Locust Wood Capital Advisers LLC, SeaTown Holdings Pte. Ltd., FIL Ltd, State of Tennessee Treasury Department, Tocqueville Asset Management L.P., and Fisher Asset Management LLC.
View insider buying and selling activity for Boston Scientific.

How do I buy shares of Boston Scientific?

Shares of BSX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Boston Scientific's stock price today?

One share of BSX stock can currently be purchased for approximately $39.49.

How big of a company is Boston Scientific?

Boston Scientific has a market capitalization of $56.50 billion and generates $10.74 billion in revenue each year. The medical equipment provider earns $4.70 billion in net income (profit) each year or $1.58 on an earnings per share basis. Boston Scientific employs 36,000 workers across the globe.

What is Boston Scientific's official website?

The official website for Boston Scientific is www.bostonscientific.com.

How can I contact Boston Scientific?

Boston Scientific's mailing address is 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH MA, 01752. The medical equipment provider can be reached via phone at 508-683-4000 or via email at [email protected]

This page was last updated on 9/18/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.